HF
LMDX

HRT Financial’s LumiraDx Limited Common Shares LMDX Stock Holding History

HRT Financial’s Portfolio LMDX Stock Details LMDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-49,944
Closed -$413K – 4325
2021
Q3 		$413K Buy
+49,944
New +$405K ﹤0.01% 2180

Other funds holding LMDX

GF
Gates Foundation Seattle, Washington $43.5M AUM 14.19% 1-Year Est. Return
SM
Senvest Management New York $3.01B AUM 35.7% 1-Year Est. Return
AM
Account Management Boxford, Massachusetts $91.3M AUM 10.03% 1-Year Est. Return
LP
LMR Partners London, United Kingdom $45.4B AUM 60.68% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
PGP
Prescott General Partners Boca Raton, Florida $1.37B AUM 23.81% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Bank of Montreal
Bank of Montreal Toronto, Ontario, Canada $269B AUM 31.4% 1-Year Est. Return
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

HRT Financial's LMDX Position: Q4 2021 in Review

HRT Financial sold out of LumiraDx Limited Common Shares (LMDX) in Q4 2021, closing a stake of 49,944 shares — an estimated $413K sold.

HRT Financial first reported a position in LMDX in Q3 2021 and held it in 1 quarter. The position peaked at $413K in Q3 2021. 21 funds tracked by Wall St. Rank hold LMDX as of Q4 2021.

  • HRT Financial reported no remaining LumiraDx Limited Common Shares position as of Q4 2021 after selling out during the quarter.
  • HRT Financial sold 49,944 LumiraDx Limited Common Shares shares in Q4 2021, an estimated $413K.
  • HRT Financial first reported a position in LumiraDx Limited Common Shares in Q3 2021 and held it in 1 quarter.
  • HRT Financial's LumiraDx Limited Common Shares position peaked at $413K in Q3 2021.
  • 21 funds tracked by Wall St. Rank held LumiraDx Limited Common Shares as of Q4 2021.

Based on HRT Financial's 13F filing for Q4 2021, filed 14 Feb 2022.